Table 2: The survival outcome between schedule modification and treatment modality (n = 124).
|
Covariates |
ACT |
NACT |
||||||
|
censored |
event |
Mean survival (95% CI) |
P value |
censored |
event |
Mean survival (95% CI) |
P value |
|
|
Schedule modification No Modification With Modification |
38 (92.7%) 40 (76.9%) |
3 (7.3%) 12 (23.1%) |
63.58 (58.79-68.37) 54.47 (47.97-60.97) |
0.04 |
6 (46.2%) 9 (50.0%) |
7 (53.8%) 9 (50.0%) |
34.76 (19.88-49.65) 34.09 (21.07 -47.11) |
0.833 |
|
Overall |
78 (83.9%) |
15 (16.1%) |
58.27 (53.85-62.70) |
15 (48.4%) |
16 (51.6%) |
35.91 (25.43-46.38) |
||